C08F 220/58
Containing oxygen in addition to the carbonamido oxygen
Official title: containing oxygen in addition to the carbonamido oxygen {, e.g. N-methylolacrylamide, N-(meth)acryloylmorpholine}
C08F220/58 (Containing oxygen in addition to the carbonamido oxygen) appears on 550 US grants and 691 published applications in this corpus.
Search patents in C08F- Granted patents
- 550
- Published applications
- 691
- Assignees
- 376
- Inventors
- 1,718
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 2 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 3 | 0 |
| 1985 | 10 | 0 |
| 1986 | 4 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 10 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 5 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 3 |
| 2002 | 6 | 2 |
| 2003 | 2 | 7 |
| 2004 | 4 | 11 |
| 2005 | 3 | 12 |
| 2006 | 6 | 14 |
| 2007 | 8 | 22 |
| 2008 | 6 | 14 |
| 2009 | 5 | 17 |
| 2010 | 17 | 29 |
| 2011 | 19 | 35 |
| 2012 | 16 | 27 |
| 2013 | 16 | 28 |
| 2014 | 17 | 36 |
| 2015 | 31 | 21 |
| 2016 | 26 | 35 |
| 2017 | 19 | 29 |
| 2018 | 25 | 40 |
| 2019 | 30 | 41 |
| 2020 | 33 | 52 |
| 2021 | 37 | 59 |
| 2022 | 29 | 52 |
| 2023 | 29 | 36 |
| 2024 | 42 | 25 |
| 2025 | 27 | 27 |
| 2026 | 11 | 17 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Contaminant remediation with functionalized (meth)acrylic polymer or copolymer macroparticulates and systems related thereto6 Oct 2026US 12,753,257 B2Countertrace LLC
- Inverse latex for a cosmetic composition comprising a specific sequestering agent and a polyelectrolyte combining a strong acid function and a weak acid function21 Jul 2026US 12,686,756 B2Societe D' Exploitation De Produits Pour Les Industries Chimiques Seppic
- Halogenated xanthene-containing topical anti-gram-positive bacterial ophthalmic composition and method23 Jun 2026US 12,661,335 B2Provectus Pharmatech, Inc.
- Manufacturing method for inverse emulsion polymer2 Jun 2026US 12,643,961 B2TouGas Holding GmbH
- Polymer excipients for biopharmaceutical formulations2 Jun 2026US 12,643,968 B2The Board of Trustees of the Leland Stanford Junior University
- Halogenated Xanthene-Containing Topical Anti-Gram-Positive Bacterial Ophthalmic Composition and Method8 Oct 2026US 2026/0306444 A1Provectus Pharmatech, Inc.
- Hydroxyl-modified binder and preparation method thereof, and secondary battery8 Oct 2026US 2026/0312057 A1Ningde Amperex Technology Limited
- Method of using inverse emulsion polymer17 Sep 2026US 2026/0275003 A1TouGas Holding GmbH
- Systems and methods for lowering water concentration in polyacrylamide-based emulsions27 Aug 2026US 2026/0250446 A1Ace Fluid Solutions
- Surface treatment agent, article, and copolymer6 Aug 2026US 2026/0226287 A1AGC Inc.
Most cited
By later US patents
- Water-swellable copolymers and articles and coatings made therefrom1,443US 7,935,773 B2Tyco Healthcare Group LP · 2011
- (Meth)acrylamide monomers containing hydroxy and silicone functionalities101US 7,396,890 B2Johnson & Johnson Vision Care, Inc. · 2008
- UV-crosslinkable materials based on (meth)acrylate polymers90US 5,128,386 ABASF SE · 1992
- Ophthalmic lens polymer incorporating acyclic monomer89US 5,311,223 AJohnson & Johnson Vision Products, Inc. · 1994
- Preparation of biologically active molecules by molecular imprinting86US 5,630,978 AYissum Research Development Company of the Hebrew University of Jerusalem · 1997